Fibroblast Activating Protein: Skimming the Surface of Molecular Imaging to Assess Fibrotic Disease Activity
Am J Respir Crit Care Med
.
2023 Jan 15;207(2):122-124.
doi: 10.1164/rccm.202208-1638ED.
Authors
Sydney B Montesi
1
,
Jeffrey C Horowitz
2
Affiliations
1
Division of Pulmonary and Critical Care Medicine Massachusetts General Hospital Boston, Massachusetts.
2
Division of Pulmonary, Critical Care and Sleep Medicine The Ohio State University Columbus, Ohio.
PMID:
36075072
PMCID:
PMC9893323
DOI:
10.1164/rccm.202208-1638ED
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Fibroblasts / pathology
Fibrosis
Humans
Lung Diseases, Interstitial* / pathology
Molecular Imaging
Grants and funding
K23 HL150331/HL/NHLBI NIH HHS/United States
R01 HL141195/HL/NHLBI NIH HHS/United States
K23HL150331/HL/NHLBI NIH HHS/United States
R01HL141195/HL/NHLBI NIH HHS/United States